Catherine E. de Keyser

1.5k total citations
17 papers, 452 citations indexed

About

Catherine E. de Keyser is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Catherine E. de Keyser has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in Catherine E. de Keyser's work include Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Nutritional Studies and Diet (4 papers). Catherine E. de Keyser is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (5 papers) and Nutritional Studies and Diet (4 papers). Catherine E. de Keyser collaborates with scholars based in Netherlands, Albania and Belgium. Catherine E. de Keyser's co-authors include Bruno H. Stricker, Albert Hofman, Rikje Ruiter, Oscar H. Franco, Jessica C. Kiefte–de Jong, Loes E. Visser, M. Carola Zillikens, Edith J. M. Feskens, Bledar Kraja and Taulant Muka and has published in prestigious journals such as Journal of Nutrition, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Catherine E. de Keyser

17 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine E. de Keyser Netherlands	13	103	93	86	79	72	17	452
Branislav Vohnout Slovakia	9	95 0.9×	94 1.0×	63 0.7×	77 1.0×	72 1.0×	20	460
Renzo Bonofiglio Italy	16	120 1.2×	111 1.2×	68 0.8×	34 0.4×	37 0.5×	52	668
Kathy Allen United States	13	132 1.3×	86 0.9×	76 0.9×	86 1.1×	68 0.9×	15	617
Alexandre Loktionov United Kingdom	7	93 0.9×	57 0.6×	50 0.6×	51 0.6×	32 0.4×	9	364
Sylvie Vass Canada	10	124 1.2×	69 0.7×	48 0.6×	80 1.0×	84 1.2×	19	607
Émilien Gauthier France	7	101 1.0×	65 0.7×	125 1.5×	62 0.8×	92 1.3×	9	488
Marinos Pericleous United Kingdom	13	124 1.2×	83 0.9×	80 0.9×	58 0.7×	55 0.8×	30	642
Bas A.J. Verhage Netherlands	20	227 2.2×	108 1.2×	133 1.5×	95 1.2×	102 1.4×	37	814
MR Law United Kingdom	6	99 1.0×	81 0.9×	229 2.7×	42 0.5×	73 1.0×	6	662
Antonio Rizza Italy	12	263 2.6×	129 1.4×	29 0.3×	91 1.2×	35 0.5×	47	689

Countries citing papers authored by Catherine E. de Keyser

Since Specialization

Citations

This map shows the geographic impact of Catherine E. de Keyser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. de Keyser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. de Keyser more than expected).

Fields of papers citing papers by Catherine E. de Keyser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. de Keyser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. de Keyser. The network helps show where Catherine E. de Keyser may publish in the future.

Co-authorship network of co-authors of Catherine E. de Keyser

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. de Keyser. A scholar is included among the top collaborators of Catherine E. de Keyser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. de Keyser. Catherine E. de Keyser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Burgh, Anna C. van der, Catherine E. de Keyser, M. Carola Zillikens, & Bruno H. Stricker. (2021). The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density. Drugs. 81(16). 1831–1858. 37 indexed citations

Keyser, Catherine E. de, et al.. (2020). A Large Skull Defect Due to Gorham-Stout Disease: Case Report and Literature Review on Pathogenesis, Diagnosis, and Treatment. Frontiers in Endocrinology. 11. 37–37. 17 indexed citations

Muka, Taulant, Bledar Kraja, Rikje Ruiter, et al.. (2016). Dietary mineral intake and lung cancer risk: the Rotterdam Study. European Journal of Nutrition. 56(4). 1637–1646. 50 indexed citations

Muka, Taulant, Bledar Kraja, Rikje Ruiter, et al.. (2016). Dietary polyunsaturated fatty acids intake modifies the positive association between serum total cholesterol and colorectal cancer risk: the Rotterdam Study. Journal of Epidemiology & Community Health. 70(9). 881–887. 16 indexed citations

Kraja, Bledar, Taulant Muka, Rikje Ruiter, et al.. (2015). Dietary Fiber Intake Modifies the Positive Association between n–3 PUFA Intake and Colorectal Cancer Risk in a Caucasian Population. Journal of Nutrition. 145(8). 1709–1716. 28 indexed citations

Keyser, Catherine E. de, Frank H. de Jong, Albert Hofman, et al.. (2015). Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study. European Journal of Endocrinology. 173(2). 155–165. 25 indexed citations

Keyser, Catherine E. de, Matthijs L. Becker, Albert Hofman, et al.. (2015). The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels. Pharmacogenetics and Genomics. 25(3). 134–142. 6 indexed citations

Mahmoudpour, Seyed Hamidreza, Folkert W. Asselbergs, Catherine E. de Keyser, et al.. (2015). Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors. International Journal of Clinical Pharmacy. 37(6). 1095–1103. 13 indexed citations

Noordam, Raymond, Nikkie Aarts, Catherine E. de Keyser, et al.. (2015). Antidepressants with a high serotonin reuptake transporter affinity and serum lipid levels in a population-based study in older adults. Journal of Psychopharmacology. 29(10). 1112–1118. 10 indexed citations

10.

Keyser, Catherine E. de, Edith M. Koehler, Jeoffrey Schouten, et al.. (2014). Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Digestive and Liver Disease. 46(8). 720–725. 35 indexed citations

11.

Keyser, Catherine E. de, Maarten J.G. Leening, Silvana Romio, et al.. (2014). Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study. European Journal of Epidemiology. 29(11). 841–850. 16 indexed citations

12.

Ruiter, Rikje, et al.. (2014). Detection bias may be the main cause of increased cancer incidence among diabetics: Results from the Rotterdam Study. European Journal of Cancer. 50(14). 2449–2455. 33 indexed citations

13.

Leusink, Maarten, Catherine E. de Keyser, N. Charlotte Onland‐Moret, et al.. (2014). No Association between CYP3A4*22 and Statin Effectiveness in Reducing the Risk for Myocardial Infarction. Pharmacogenomics. 15(11). 1471–1477. 9 indexed citations

14.

Ruiter, Rikje, Edith J. M. Feskens, Catherine E. de Keyser, et al.. (2014). Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: The Rotterdam study. International Journal of Cancer. 136(9). 2178–2186. 96 indexed citations

15.

Keyser, Catherine E. de, Bas Peters, Matthijs L. Becker, et al.. (2013). The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study. Pharmacogenetics and Genomics. 24(1). 43–51. 35 indexed citations

16.

Keyser, Catherine E. de, Matthijs L. Becker, André G. Uitterlinden, et al.. (2013). Genetic Variation in thePPARAGene is Associated with Simvastatin-Mediated Cholesterol Reduction in the Rotterdam Study. Pharmacogenomics. 14(11). 1295–1304. 14 indexed citations

17.

Keyser, Catherine E. de, Mark Eijgelsheim, Albert Hofman, et al.. (2010). Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study. The Pharmacogenomics Journal. 11(1). 72–80. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact